e-learning
resources
Virtual 2020
Pre-Congress Content
Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Essential trace element levels in IPF patients: a case control study
C. Simsek (Ankara, Turkey), G. Bakici Sari (Ankara, Turkey), B. Akgündüz (Ankara, Turkey), V. Türksoy (Yozgat, Turkey), Y. Agaçkiran (Ankara, Turkey), N. Tezer (Ankara, Turkey), D. Özdemir (Ankara, Turkey)
Source:
Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session:
Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session type:
E-poster session
Number:
728
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Simsek (Ankara, Turkey), G. Bakici Sari (Ankara, Turkey), B. Akgündüz (Ankara, Turkey), V. Türksoy (Yozgat, Turkey), Y. Agaçkiran (Ankara, Turkey), N. Tezer (Ankara, Turkey), D. Özdemir (Ankara, Turkey). Essential trace element levels in IPF patients: a case control study. 728
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Special features of pulmonary tuberculosis among smokers: A case control study
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
High « red cell distribution width » levels can predict pulmonary embolism risk in multiple trauma patients: a case control study.
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015
Year: 2017
Medication use in children with asthma: a case control study
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001
Smoking and pulmonary tuberculosis: a case control study
Source: Eur Respir J 2005; 26: Suppl. 49, 190s
Year: 2005
Measuring patient activation in an interstitial lung disease (ILD) population: an exploratory study
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Role of complement activation product C4d as apredictor biomarker in lung cancer diagnosis : case control study
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Phenotypic characterisation of early COPD: a prospective case–control study
Source: ERJ Open Res, 6 (4) 00047-2020; 10.1183/23120541.00047-2020
Year: 2020
Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study
Source: Eur Respir J 2007; 30: Suppl. 51, 147s
Year: 2007
A COPD patient case study
Source: Annual Congress 2012 - NIV - Meeting the Experts: From state-of-the-art to new technologies
Year: 2012
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Relationship between level of asthma control and stability: GOAL study
Source: Eur Respir J 2006; 28: Suppl. 50, 318s
Year: 2006
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Asthma control and management in Spain, a study of factors associated to asthma control (CHAS study)
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008
Difference in asthma control levels by assessment tools: Observational study
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Low agreement between current and long-term asthma control in children: The PACMAN cohort study
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept